Biosimilar Tier News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Experts review best practices around plan design that payers and plan sponsors should address as more interchangeable biosimilars potentially enter the market.

Jonathan kayKimberlyc chenRyan haumschildMaia kayalInterchangeable biosimilarPlan designPayer perspectivePlan sponsorBiosimilar tier